- Home
- TLSI vs INBK Comparison
TLSI vs INBK Comparison
Compare TLSI & INBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- INBK
- Stock Information
- Founded
- TLSI 2010
- INBK 1999
- Country
- TLSI United States
- INBK United States
- Employees
- TLSI N/A
- INBK N/A
- Industry
- TLSI Medical Specialities
- INBK Major Banks
- Sector
- TLSI Health Care
- INBK Finance
- Exchange
- TLSI Nasdaq
- INBK Nasdaq
- Market Cap
- TLSI 204.0M
- INBK 196.2M
- IPO Year
- TLSI N/A
- INBK N/A
- Fundamental
- Price
- TLSI $5.43
- INBK $27.18
- Analyst Decision
- TLSI Strong Buy
- INBK Buy
- Analyst Count
- TLSI 5
- INBK 4
- Target Price
- TLSI $10.90
- INBK $34.50
- AVG Volume (30 Days)
- TLSI 146.8K
- INBK 41.3K
- Earning Date
- TLSI 08-13-2025
- INBK 07-23-2025
- Dividend Yield
- TLSI N/A
- INBK 0.86%
- EPS Growth
- TLSI N/A
- INBK 27.37
- EPS
- TLSI N/A
- INBK 2.40
- Revenue
- TLSI $32,141,000.00
- INBK $114,609,000.00
- Revenue This Year
- TLSI $55.52
- INBK $5.36
- Revenue Next Year
- TLSI $54.76
- INBK $17.09
- P/E Ratio
- TLSI N/A
- INBK $11.37
- Revenue Growth
- TLSI 46.20
- INBK 20.13
- 52 Week Low
- TLSI $3.50
- INBK $19.54
- 52 Week High
- TLSI $6.04
- INBK $43.27
- Technical
- Relative Strength Index (RSI)
- TLSI 50.01
- INBK 72.08
- Support Level
- TLSI $5.18
- INBK $22.96
- Resistance Level
- TLSI $5.65
- INBK $24.67
- Average True Range (ATR)
- TLSI 0.35
- INBK 0.88
- MACD
- TLSI -0.02
- INBK 0.44
- Stochastic Oscillator
- TLSI 49.23
- INBK 93.01
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.